349 related articles for article (PubMed ID: 11981142)
1. Dextromethorphan and memantine in painful diabetic neuropathy and postherpetic neuralgia: efficacy and dose-response trials.
Sang CN; Booher S; Gilron I; Parada S; Max MB
Anesthesiology; 2002 May; 96(5):1053-61. PubMed ID: 11981142
[TBL] [Abstract][Full Text] [Related]
2. High-dose oral dextromethorphan versus placebo in painful diabetic neuropathy and postherpetic neuralgia.
Nelson KA; Park KM; Robinovitz E; Tsigos C; Max MB
Neurology; 1997 May; 48(5):1212-8. PubMed ID: 9153445
[TBL] [Abstract][Full Text] [Related]
3. Rationale and design of a multicenter randomized clinical trial with memantine and dextromethorphan in ketamine-responder patients.
Pickering G; Pereira B; Morel V; Tiberghien F; Martin E; Marcaillou F; Picard P; Delage N; de Montgazon G; Sorel M; Roux D; Dubray C
Contemp Clin Trials; 2014 Jul; 38(2):314-20. PubMed ID: 24948402
[TBL] [Abstract][Full Text] [Related]
4. Rationale and design of a randomized double-blind clinical trial in breast cancer: dextromethorphan in chemotherapy-induced peripheral neuropathy.
Martin E; Morel V; Joly D; Villatte C; Delage N; Dubray C; Pereira B; Pickering G
Contemp Clin Trials; 2015 Mar; 41():146-51. PubMed ID: 25636304
[TBL] [Abstract][Full Text] [Related]
5. Dextromethorphan and memantine after ketamine analgesia: a randomized control trial.
Martin E; Sorel M; Morel V; Marcaillou F; Picard P; Delage N; Tiberghien F; Crosmary MC; Najjar M; Colamarino R; Créach C; Lietar B; Brumauld de Montgazon G; Margot-Duclot A; Loriot MA; Narjoz C; Lambert C; Pereira B; Pickering G
Drug Des Devel Ther; 2019; 13():2677-2688. PubMed ID: 31447547
[TBL] [Abstract][Full Text] [Related]
6. Four years' treatment with ketamine and a trial of dextromethorphan in a patient with severe post-herpetic neuralgia.
Klepstad P; Borchgrevink PC
Acta Anaesthesiol Scand; 1997 Mar; 41(3):422-6. PubMed ID: 9113190
[TBL] [Abstract][Full Text] [Related]
7. Lack of efficacy of dextromethorphan in managing alcohol withdrawal: a preliminary report of a randomized, double-blind, placebo-controlled trial.
Huang MC; Chen CH; Pan CH; Lin SK
J Clin Psychopharmacol; 2014 Feb; 34(1):149-52. PubMed ID: 24346753
[TBL] [Abstract][Full Text] [Related]
8. Dextromethorphan and diabetic neuropathy.
Criner TM; Perdun CS
Ann Pharmacother; 1999 Nov; 33(11):1221-3. PubMed ID: 10573324
[TBL] [Abstract][Full Text] [Related]
9. [NMDA receptor antagonists: a new treatment for neuropathic pain].
Pud D; Eisenberg E
Harefuah; 1999 Apr; 136(7):564-7. PubMed ID: 15532603
[No Abstract] [Full Text] [Related]
10. Low doses of dextromethorphan have a beneficial effect in the treatment of neuropathic pain.
Morel V; Pickering G; Etienne M; Dupuis A; Privat AM; Chalus M; Eschalier A; Daulhac L
Fundam Clin Pharmacol; 2014 Dec; 28(6):671-80. PubMed ID: 24702319
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of dextromethorphan/quinidine at two dosage levels for diabetic neuropathic pain: a double-blind, placebo-controlled, multicenter study.
Shaibani AI; Pope LE; Thisted R; Hepner A
Pain Med; 2012 Feb; 13(2):243-54. PubMed ID: 22314263
[TBL] [Abstract][Full Text] [Related]
12. A randomized, controlled trial of high-dose dextromethorphan in facial neuralgias.
Gilron I; Booher SL; Rowan MS; Smoller MS; Max MB
Neurology; 2000 Oct; 55(7):964-71. PubMed ID: 11061252
[TBL] [Abstract][Full Text] [Related]
13. Assessment of the effect of dextromethorphan and ketamine on the acute nociceptive threshold and wind-up of the second pain response in healthy male volunteers.
Hughes AM; Rhodes J; Fisher G; Sellers M; Growcott JW
Br J Clin Pharmacol; 2002 Jun; 53(6):604-12. PubMed ID: 12047485
[TBL] [Abstract][Full Text] [Related]
14. Memantine for the treatment of general neuropathic pain: a narrative review.
Pickering G; Morel V
Fundam Clin Pharmacol; 2018 Feb; 32(1):4-13. PubMed ID: 28802070
[TBL] [Abstract][Full Text] [Related]
15. Analgesic effect of dextromethorphan in neuropathic pain.
Carlsson KC; Hoem NO; Moberg ER; Mathisen LC
Acta Anaesthesiol Scand; 2004 Mar; 48(3):328-36. PubMed ID: 14982566
[TBL] [Abstract][Full Text] [Related]
16. A placebo-controlled randomized crossover trial of the N-methyl-D-aspartic acid receptor antagonist, memantine, in patients with chronic phantom limb pain.
Wiech K; Kiefer RT; Töpfner S; Preissl H; Braun C; Unertl K; Flor H; Birbaumer N
Anesth Analg; 2004 Feb; 98(2):408-413. PubMed ID: 14742379
[TBL] [Abstract][Full Text] [Related]
17. Dextromethorphan and quinidine in adult patients with uncontrolled painful diabetic peripheral neuropathy: a 29-day, multicenter, open-label, dose-escalation study.
Thisted RA; Klaff L; Schwartz SL; Wymer JP; Culligan NW; Gerard G; Pope LE; Berg JE
Clin Ther; 2006 Oct; 28(10):1607-18. PubMed ID: 17157116
[TBL] [Abstract][Full Text] [Related]
18. A randomized, controlled trial of oxycodone versus placebo in patients with postherpetic neuralgia and painful diabetic neuropathy treated with pregabalin.
Zin CS; Nissen LM; O'Callaghan JP; Duffull SB; Smith MT; Moore BJ
J Pain; 2010 May; 11(5):462-71. PubMed ID: 19962354
[TBL] [Abstract][Full Text] [Related]
19. Analgesic therapy in postherpetic neuralgia: a quantitative systematic review.
Hempenstall K; Nurmikko TJ; Johnson RW; A'Hern RP; Rice AS
PLoS Med; 2005 Jul; 2(7):e164. PubMed ID: 16013891
[TBL] [Abstract][Full Text] [Related]
20. NMDA receptor antagonists for the treatment of neuropathic pain.
Collins S; Sigtermans MJ; Dahan A; Zuurmond WW; Perez RS
Pain Med; 2010 Nov; 11(11):1726-42. PubMed ID: 21044263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
